A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT03422328
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 151 participants
- Sponsor
- Registry
-
NCT03422328 -
2017-003934-10
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belarus, Belgium, France, Poland, Russia, Türkiye, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT03422328. Allocation not applicable; no masking; primary purpose treatment. Start 2018-04-05 (actual); primary completion 2023-12-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
- Acronym
- UMBRELLA
- Condition
- Pulmonary Arterial Hypertension
- Condition
- Chronic Thromboembolic Pulmonary Hypertension
- Intervention (Drug)
- macitentan
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct03422328- Content hash
68eed971df7d9285113e044763e37270fea4d7f6b9986c421b93b1ad3b607755